United States
Global Photon is a biotechnology and healthcare startup based in the United States, founded in 2004. The company has developed a patented science delivered through a non-invasive medical device called Lazarus. The primary focus of Global Photon is to improve the lives of cancer patients suffering from the side effects of chemotherapy and radiation. Lazarus utilizes a unique Photonic light technology to alleviate pain, nausea, sleeplessness, migraines, compromised immune systems, and prevent chemotherapy-induced peripheral neuropathy (CIPN).
The company's primary objective is to improve the quality of life for millions of cancer patients globally and mitigate or eliminate the harmful side effects of chemotherapy and radiation treatments. Lazarus is awaiting FDA clearance and will be available in the United States in a choice of three colors: blue, silver, and charcoal.
Furthermore, Global Photon aims to improve the quality of life for millions of people globally suffering from peripheral neuropathy and other debilitating conditions. The company is based in Austin, Texas, known as the technology capital of the Southwest. The most recent investment in Global Photon was a $25.00K venture round investment on 18 July 2012.
